Silicon Valley's Secret: Tech Elite Use Gray-Market "Chinese Peptides" for Biohacking
Part of composite article Asia's Nuclear Crossroads: Allies Rethink Defense Amid U.S. Uncertainty View full article →
A new, unregulated trend is spreading through Silicon Valley. Tech workers are using gray-market drugs known as "Chinese peptides" in their pursuit of enhanced health and performance.
These substances are synthetic versions of compounds found in the human body. Users believe they can improve healing, build muscle, and reverse aging. The peptides are often ordered online from Chinese laboratories and shipped directly to buyers.
This practice reveals a core belief in parts of the tech community: that they can innovate faster than traditional systems. They are choosing to bypass the U.S. Food and Drug Administration (F.D.A.), which has not approved these peptides for most uses.
The F.D.A. warns that products from unknown sources can be dangerous. They may contain incorrect ingredients, contaminants, or unsafe dosage levels. Medical experts say using them is a significant health risk.
Despite these warnings, demand continues. For this community, the potential reward of a biohacking breakthrough is worth the legal and physical risks.